In an encephalomyelitis mouse model, supplementation with Trp or Trp-derived aryl hydrocarbon receptor (AhR) agonists increased IFN-suppressive effects in an AhR-dependent manner and reduced central nervous system inflammation (17). Here, AHR is linked to encephalomyelitis.